Early detection of colorectal neoplasia significantly reduces mortality from colorectal cancer (CRC), and numerous screening options exist. Guidelines for CRC screening from US and international professional societies provide menus of options based on strength of evidence. Despite availability of screening and its proven impact, 40% of guideline-eligible patients are not screened as recommended in the United States. Adherence to or uptake of CRC screening is especially poor among underserved populations, including those with low income and African American and Hispanic populations. Consideration of screening options must not only take into account test performance, but issues of resources and individual versus population benefits.
Keywords: Artificial intelligence; Colorectal cancer screening; Early-onset colorectal cancer; Guidelines; Non-invasive screening tests; Quality colonoscopy; Underserved populations.
Copyright © 2022 Elsevier Inc. All rights reserved.